FIELD: medicine.
SUBSTANCE: method involves chelation of ferric (III) ions both in vivo, and in vitro with using 2-ethyl-6-methyl-3-hydroxypyridine succinate (Mexidol) to produce a stable stained complex having a high molecular weight and a complex (organic-inorganic) composition not identified among the known compounds.
EFFECT: high effectiveness of the chelation process and low toxicity of Mexidol that makes it promising for biomedical application.
4 dwg, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING BIOLOGICALLY ACTIVE NANOLIQUID OF FERRIC OXIDE (II, III) NANOPARTICLES AND 3-HYDROXY PYRIDINE DERIVATIVE | 2012 |
|
RU2493857C1 |
| NEUROTROPIC PREPARATION, POSSESSING ANTI-HYPOXIC, NEUROPROTECTIVE, ANTI-AMNESTIC AND VESTIBULAR-PROTECTIVE ACTIVITY | 2014 |
|
RU2547728C1 |
| AGENT FOR TREATMENT OF DISEASE CAUSED BY OXIDATIVE STRESS | 2018 |
|
RU2674286C1 |
| USE OF PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE ALFOSCERATE AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE AS NEUROPROTECTIVE AGENT IN CEREBRAL ISCHEMIA | 2023 |
|
RU2819828C1 |
| METHOD OF OBTAINING 2-OXO-4-CYANO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDES | 2011 |
|
RU2475480C1 |
| MEDICATION WHICH POSSESSES ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2440814C1 |
| DRUG POSSESSING ACTOPROTECTIVE, ANTIHYPOXIC, NEUROPROTECTIVE, ANTIAMNESTIC AND THERMOPROTECTIVE ACTIVITY | 2011 |
|
RU2460529C1 |
| METHOD FOR FRACTIONATION OF BIOFLAVONOID COMPLEX OF SEA BUCKTHORN MEAL | 2020 |
|
RU2759297C1 |
| COMPOSITIONS AND METHODS OF TREATING ZYGOMYCOSIS AND OTHER FUNGOID DISEASES | 2007 |
|
RU2464024C2 |
| METHOD FOR INHIBITING NUCLEAR KAPPA B FACTOR WITH USING 2-ETHYL-6-METHYL-3-HYDROXIPIRIDINIUM L-2,6-DIAMINOHEXANOATE IN CULTURE OF CELLS | 2017 |
|
RU2669348C1 |
